1. Home
  2. PCVX vs QLYS Comparison

PCVX vs QLYS Comparison

Compare PCVX & QLYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PCVX
  • QLYS
  • Stock Information
  • Founded
  • PCVX 2013
  • QLYS 1999
  • Country
  • PCVX United States
  • QLYS United States
  • Employees
  • PCVX N/A
  • QLYS N/A
  • Industry
  • PCVX Biotechnology: Pharmaceutical Preparations
  • QLYS Computer Software: Prepackaged Software
  • Sector
  • PCVX Health Care
  • QLYS Technology
  • Exchange
  • PCVX Nasdaq
  • QLYS Nasdaq
  • Market Cap
  • PCVX 4.0B
  • QLYS 4.7B
  • IPO Year
  • PCVX 2020
  • QLYS 2012
  • Fundamental
  • Price
  • PCVX $33.02
  • QLYS $134.95
  • Analyst Decision
  • PCVX Strong Buy
  • QLYS Hold
  • Analyst Count
  • PCVX 8
  • QLYS 15
  • Target Price
  • PCVX $135.00
  • QLYS $141.00
  • AVG Volume (30 Days)
  • PCVX 1.5M
  • QLYS 290.1K
  • Earning Date
  • PCVX 11-04-2025
  • QLYS 11-04-2025
  • Dividend Yield
  • PCVX N/A
  • QLYS N/A
  • EPS Growth
  • PCVX N/A
  • QLYS 10.84
  • EPS
  • PCVX N/A
  • QLYS 5.02
  • Revenue
  • PCVX N/A
  • QLYS $637,019,000.00
  • Revenue This Year
  • PCVX N/A
  • QLYS $10.58
  • Revenue Next Year
  • PCVX N/A
  • QLYS $6.44
  • P/E Ratio
  • PCVX N/A
  • QLYS $26.89
  • Revenue Growth
  • PCVX N/A
  • QLYS 9.63
  • 52 Week Low
  • PCVX $27.66
  • QLYS $112.61
  • 52 Week High
  • PCVX $121.06
  • QLYS $170.00
  • Technical
  • Relative Strength Index (RSI)
  • PCVX 55.75
  • QLYS 52.30
  • Support Level
  • PCVX $30.89
  • QLYS $131.36
  • Resistance Level
  • PCVX $32.32
  • QLYS $136.47
  • Average True Range (ATR)
  • PCVX 1.19
  • QLYS 2.82
  • MACD
  • PCVX 0.30
  • QLYS 0.61
  • Stochastic Oscillator
  • PCVX 84.68
  • QLYS 72.48

About PCVX Vaxcyte Inc.

Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.

About QLYS Qualys Inc.

Qualys is a cloud security and compliance solutions provider that helps businesses identify and manage their security risks and compliance requirements. The California-based company has more than 10,000 customers worldwide, the majority of which are small- and medium-size businesses. Qualys was founded in 1999 and went public in 2012.

Share on Social Networks: